Company Filing History:
Years Active: 2016-2017
Title: Nathalie Meurice: Innovator in Biomedical Research
Introduction
Nathalie Meurice is a prominent inventor based in Scottsdale, AZ (US). She has made significant contributions to the field of biomedical research, particularly in the area of therapeutic compounds. With a total of 2 patents, her work focuses on innovative methods for treating cell proliferative disorders.
Latest Patents
Nathalie's latest patents include a method of screening for a compound for inhibitory activity of FN14-TWEAK interaction. This patent outlines methods for screening compounds that modulate activity at a TNF-like weak inducer of apoptosis (TWEAK) binding site on a cysteine-rich domain (CRD) of fibroblast growth factor-inducible 14 (Fn14). Additionally, she has developed a patent for FN14 antagonists and their therapeutic uses, which details methods for using Fn14 antagonists to modulate activity at the TWEAK binding site. This patent also provides pharmaceutical compositions that include synergistic combinations of Fn14 antagonists and chemotherapeutic agents.
Career Highlights
Nathalie Meurice is affiliated with the Translational Genomics Research Institute, where she continues to advance her research. Her work has been instrumental in developing new therapeutic strategies that could potentially improve patient outcomes in various medical conditions.
Collaborations
Some of her notable coworkers include Nhan L Tran and Harshil Dineshkumar Dhruv, who contribute to her research endeavors.
Conclusion
Nathalie Meurice is a trailblazer in the field of biomedical research, with her innovative patents paving the way for new treatments. Her dedication to advancing medical science is evident in her work and collaborations.